Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate
O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate
  • O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate

O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate

Price Get Latest Price
Package 1g 100g 1000g
Min. Order: 1g
Supply Ability: 10 kg
Update Time: 2023-04-18

Product Details

Product Name: O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate CAS No.: 206111-36-6
Min. Order: 1g Purity: 97% O1-tert-butyl O4-ethyl ( )-(3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate
Supply Ability: 10 kg Release date: 2023/04/18

synthesis through bio-catalyst, high purity, low cost, environmental friendly, and heavy mental free


Company Profile Introduction

Founded in June 2020, ChiRial is a manufacturer of biosynthesis biomaterials, which integrates R&D, production and sales. ChiRial has gathered a group of experts with multidisciplinary research and industrialization backgrounds in biology, chemistry, bio-medicine, and computer science, etc. Based on the multidisciplinary resources and core innovative experience, ChiRial has built a number of platform technologies, such as Computation Analysis, Directed Evolution of Enzymes, Biological Fermentation Engineering, Green Chiral Chemistry and Polymerization and performance testing of biomaterials (PHA).

You may like

Recommended supplier

Product name Price   Suppliers Update time
$500.00/1KG
VIP6Y
Anhui Dexinjia Biopharm Co., Ltd
2021-01-21
$3.00/1kg
VIP3Y
Hebei Fengjia New Material Co., Ltd
2024-09-05
$300.00/1kg
VIP1Y
Sach biotech Co.,Ltd
2024-07-05
  • Since: 2020-06-10
  • Address: 14F, Building A, 3-1 Xinjinhu Rd Nanjing, Jiangsu, P.R.China
INQUIRY